Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

ClickSlim vs MultiMedRx

ClickSlim
Graded #490

Lower grade

vs+7.700000000000003
MultiMedRx
Graded #394

Higher grade

The verdict

MultiMedRx takes it — 57.6/100 to 49.9/100.

MultiMedRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MultiMedRx is a LegitScript-certified telehealth platform with physical offices in Newport Beach, CA and Reno, NV.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMultiMedRx +13
32
45
Dose & formulationMultiMedRx +1
52
53
Clinical oversightMultiMedRx +19
60
79
Labs & monitoringMultiMedRx +1
52
53
FulfillmentMultiMedRx +2
65
67
Contract termsEven
49
49
ClickSlim · left barMultiMedRx · right bar

The numbers

MetricClickSlimMultiMedRx
WeighScore49.9/10057.6/100
GradeCC
Scorecard rank#490#394
SemaglutideNot disclosedNot disclosed
Tirzepatide$349/mo (compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
ClickSlim

Graded #490 · C

Strengths

  • Both the introductory and the ongoing price are published, so the step-up is visible before you buy
  • States plainly that it is not a pharmacy or a drug manufacturer and that medication is dispensed by a licensed third party
  • Text support line published with stated hours
  • LegitScript certification verified against the issued seal, not just the badge

Where it loses points

  • Its own NAD+ product card is labelled CONTAINS TIRZEPATIDE, which contradicts the product it is selling
  • No state list is published; the site says only that services are available in most States
  • Prices are among the highest in the category, at $349 ongoing for tirzepatide
  • Registered at a Sheridan, Wyoming suite address commonly used as a mail-forwarding and registered-agent address
  • Terms set arbitration in San Diego under California law while the company address is in Wyoming
MultiMedRx

Graded #394 · C

Strengths

  • Legal entity disclosed (MMRX MultiMedRx LLC) — uncommon transparency
  • Two physical addresses listed: Newport Beach, CA and Reno, NV
  • LegitScript seal present
  • Features brand-name GLP-1s (Ozempic, Wegovy, Zepbound) — rare in a mostly compounded-only field
  • Broader cardiometabolic menu (metformin, testosterone, HRT) alongside GLP-1

Where it loses points

  • No Mounjaro or Foundayo in the brand-name lineup (only Ozempic, Wegovy, Zepbound)
  • Monthly GLP-1 pricing isn't published — gated behind the consultation
  • $100 consultation fee adds friction; many peers bundle it into the medication price
  • Per-state availability not listed; only CA and NV offices disclosed
  • Whether compounded GLP-1 is offered isn't clear — verify during intake

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard